|
Dr. Robert McNally graduated with a Ph.D. in Biomedical Engineering from the University of Pennsylvania and has over 28 years of experience in academic and corporate clinical investigations management research business quality and regulatory affairs.
Dr. McNally is the President and CEO of GeoVax. Previously he served as President as well as VP of Quality Assurance of Cell Dynamics a company he co-founded. Cell Dynamics worked with organ and tissue procurement organizations for the recovery of human tissue processing these tissues into cellular components necessary for research and development pharmaceuticals and cell therapy. In 1984 Dr. McNally co-founded CryoLife Inc. a company specializing in the cryopreservation of human tissue for transplant. During his 14 year association with CryoLife it grew to $50M in revenue became a public company on NYSE and received world recognition as a leader in transplant technology.
He is a Fellow of the American Institute of Medical and Biological Engineers serves on the board of the Petit Institute for Tissue Engineering at Georgia Tech and is Past Chairman of the Georgia Biomedical Partnership and recipient of its 2005 Biomedical Industry Growth Award.
| 